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Background: Tako-Tsubo cardiomyopathy (TTC) is a rare disorder with high relevance for anaesthesia. It is an acute
cardiac syndrome characterized by an acute onset of reversible left ventricular dysfunction associated with
emotional and physical stress. This is the only case published of a patient having five severe Tako-Tsubo incidents
in five consecutive general anaesthesia procedures within one year.
Case presentation: A 61 years old female patient (height 1.65 m; weight 70 kg) presented with a haemorrhagic
pituitary adenoma with compression of the optic chiasm and was scheduled for transnasal endoscopic tumour
resection. We report a case series with five consecutive anaesthesia procedures in the same patient for
neurosurgery.
This case series is remarkable since the severe symptoms occurred during every anaesthesia procedure. The female
patient was resuscitated two times including therapeutic hypothermia, but fortunately no neurological or cognitive
deficit was detectable.
Conclusions: TTC may initially present in the perioperative period with pulmonary oedema, electrocardiographic
(ECG) changes, elevation of cardiac enzymes, and cardiogenic shock or cardiac arrest.
Since the risk of recurrence is considered to be low in TTC, this case report is of high interest. In each procedure
similar clinical signs were found which resulted in severe haemodynamic derangements in every manifestation and
cardiac arrest in two of the manifestations. Despite cardiopulmonary resuscitation twice, the patient survived
without any neurological deficiency.
Keywords: Tako-Tsubo cardiomyopathy, Broken heart syndrome, Transient left-ventricular apical ballooning
syndrome, Stress-induced cardiomyopathy, Ampulla cardiomyopathyBackground
Tako-Tsubo cardiomyopathy (TTC) is a rare disorder
with an annual incidence of approximately 0.00006% [1].
This syndrome was first described in Japan in 1990 [2].
It is also known as “takotsubo syndrome” [3,4], “broken
heart syndrome” [4,5], “transient left-ventricular apical
ballooning syndrome” [5-7], “stress-induced cardiomy-
opathy” [5,8], “ampulla cardiomyopathy” [4,8], or “stress-
induced myocardial stunning” [9,10]. Although the
syndrome is usually induced by a sudden stress reaction,
symptoms may also occur without any detectable cause.* Correspondence: jochen.hinkelbein@uk-koeln.de
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unless otherwise stated.The syndrome usually manifests like acute myocar-
dial infarction but is characterized by generally re-
versible left ventricular dysfunction with typical akinesia
of the apical segments and hypercontractility of the basal
segments and is associated with emotional or physical
stress (Figure 1) [5,7,10].
It occurs most often in post-menopausal women and
it is usually triggered by emotional or physical stress, with
complete recovery of left ventricular systolic function
within a few days or weeks. For diagnosis, significant cor-
onary artery disease has to be absent [5]. The diagnosis of
TTC should be based on the following Mayo Clinic cri-
teria [11]: (a) transient akinesia or dyskinesia of left ven-
tricular apical and/or midventricular segments; (b) no
angiographic evidence > 50% coronary artery stenosis, ortral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Normal heart (A) and Tako-Tsubo sign (B) with apical ballooning (end-systolic view).
Hinkelbein et al. BMC Anesthesiology  (2015) 15:39 Page 2 of 8plaque rupture, or intracoronary thrombus formation; (c)
new electrocardiographic (ECG) abnormalities (dynamic
ST-T changes or T-wave inversion); (d) absence of intra-
cranial bleeding, phaeochromocytoma, and myocarditis.
Tako-Tsubo cardiomyopathy may initially present in
the perioperative period with pulmonary oedema, ECG
changes, elevation of cardiac enzymes, and cardiogenic
shock or cardiac arrest [7,12]. Many reports show the
onset in the preoperative [13] and postoperative period
[3,7,12,14,15] without an association to anaesthesia. Only
few onsets are reported to happen in the intraoperative
period [7,16,17], during anaesthesia or anaesthesia induction.
The risk of recurrence is generally considered to be very
low [6]. Yet there are two case series published reporting
of three general/regional anaesthesia procedures in pa-
tients with Tako-Tsubo cardiomyopathy [7,18].
Although extensive literature research was performed
by our team, we did not find any other case series of pa-
tients receiving repetitive anaesthesia. Here we report on
a case of a female patient, having 5 severe TTC incidents
in 5 consecutive procedures under general anaesthesia
within sixteen months.
Consent
Since this report is a case report, no ethical committee
statement is available. Written informed consent was ob-
tained from the patient for publication of this Case report
and any accompanying images. A copy of the written con-
sent is available for review by the Editor of this journal.
Case presentation
A 61 years old female patient (height 1.65 m; weight
70 kg) presented with a haemorrhagic pituitary adenoma
with compression of the optic chiasm and was scheduled
for transnasal endoscopic tumour resection. During the
preoperative consultation by an anaesthesiologist, she re-
ported of intermittent extrasystolia why she underwentcoronary diagnostics two years before. At that time diag-
nostics were uneventful and coronary heart disease
(CHD) had been excluded by coronary angiography. Pre-
operative anaesthesia evaluation including ECG (Figure 2)
and blood analysis was unremarkable. Both physical exam-
ination and history were uneventful (last surgery >20 yrs
before without known problems).
Anaesthesia #1 (March 12, 2012)
Surgery was scheduled and the patient was considered
for general anaesthesia. The patient was pre-medicated
with midazolam 7.5 mg orally prior to arrival in the OR.
Basic monitoring (ECG, pulse oximetry and non-invasive
blood pressure (NIBP) measurement) was applied and a
peripheral venous line was installed. For induction of anaes-
thesia, sufentanil 70 μg, propofol 150 mg, and atracurium
50 mg i.v. were used. During induction the endotracheal
tube was placed successfully in the second attempt by the
anaesthetist due to a slightly difficult airway (Cormack &
Lehane Score, C&L III). The initial course of anaesthesia
was uneventful except for a bradycardia (27 bpm) which
was treated with 0.5 mg atropine intravenously (i.v.). Dur-
ing the surgical transnasal approach, the patient suddenly
developed significant ST segment elevation followed by
ventricular fibrillation (VF) being treated by basic and ad-
vanced life support (BLS, ALS) for 5 minutes including
the intermittent use of intravenous epinephrine and one
single defibrillation. Thus, surgery was aborted before
starting tumour resection and the patient transported for
coronary angiography. Since no coronary heart disease
(CHD) was found and the ventriculogram showed typical
regional wall motion abnormality with apical ballooning,
the diagnosis of Tako-Tsubo cardiomyopathy was stated
according to the Mayo Clinic guidelines [11] by a special-
ist for cardiology. The further course on the Intensive
Care Unit (ICU) was uneventful and the patient was extu-
bated several hours later. There was no neurological or
Figure 2 Resting ECG of the patient.
Hinkelbein et al. BMC Anesthesiology  (2015) 15:39 Page 3 of 8cognitive deficit detectable. At day 2 the patient was
discharged from ICU to the normal ward without wall
motion abnormalities (trans-thoracic echocardiography,
TTE). Since surgery had to be aborted without initiating
resection of the tumour, it was scheduled two months
later. The patient was asymptomatic in the meanwhile.
Anaesthesia #2 (May 4, 2012)
To prevent potential recurrence of TTC, the complete
team was instructed prior to anaesthesia and surgery.
The patient was pre-medicated with midazolam 7.5 mg
orally prior to arrival in the OR. Basic monitoring was ap-
plied and a peripheral venous line was installed. For in-
duction of anaesthesia, sufentanil 50 μg, propofol 200 mg,
and atracurium 30 mg i.v. were used. Both induction of
anaesthesia and the course of surgery were uneventful ex-
cept for an intermittent ST-segment elevation and an ac-
companying hypotension which were controlled by a
single bolus injection of norepinephrine (20 μg). The fur-
ther course of surgery and hospital stay presented without
any abnormalities.
Anaesthesia #3 (Aug 28, 2012)
Again, transnasal surgical decompression became neces-
sary because of development of a symptomatic intra- and
suprasellar cystic lesion highly suspicious of an abscess at
the former tumour site. The patient was pre-medicated
with midazolam 7.5 mg orally prior to arrival in the OR.
After applying basic monitoring and a peripheral venousline, an arterial cannula was inserted into the patient being
awake. For induction of anaesthesia, sufentanil 50 μg, pro-
pofol 180 mg, and atracurium 40 mg i.v. were used. Right
after intravenous induction of anaesthesia and well before
surgical preparation and positioning of the patient, again,
the patient suddenly developed significant ST segment ele-
vation followed by a pulseless electrical activity (PEA) and
intermittent VF which were, again, treated by basic and
advanced life support (BLS, ALS), epinephrine, and de-
fibrillation. Return of spontaneous circulation (ROSC)
was achieved after 30 minutes of cardiopulmonary resus-
citation (CPR). Due to suspicion of an acute myocardial
infarction, anti-coagulative treatment was started with
acetylsalicylic acid along with heparin.
Since haemodynamics were insufficient and extensive
inotropic and vasopressor support was required (norepin-
ephrine 1,000 μg/h and epinephrine 2,500 μg/h by a syr-
inge pump), cannulation for emergency extracorporeal
membrane oxygenation (ECMO) was discussed but at last
not performed due to increasing haemodynamic stability
to a tolerable level. Since inotropic support was steady but
still high-level at this time, surgery was cancelled and the
patient transported to ICU for induction of therapeutic
hypothermia and improvement of the haemodynamic
situation, which was successful.
The further course on ICU was uneventful and, there-
fore, surgery was performed 8 days later after full recovery
of the cardiac function (trans-thoracic echocardiography)
without any problems in the still sedated and ventilated
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treated by surgical evacuation and postoperative anti-
biotics. After surgery, the patient was extubated and
discharged from ICU at day 12. Again, there was no
neurological or cognitive deficit detectable.
Anaesthesia #4 (Feb 25, 2013)
In spite of adequate surgical and medical therapy of the
primary lesion, a recurrence of the abscess was detected
several months later. The patient was necessarily pre-
sented again for anaesthesia and surgery. In order to
provide a maximum of safety for the patient, extensive,
interdisciplinary preoperative arrangements were made
between anaesthetists, nurses, and surgeons (transfer to
the operating room (OR), two experienced senior spe-
cialists for anaesthesia, medical equipment, monitoring
devices, postoperative, and crisis management).
The patient was orally pre-medicated with lorazepam
1 mg at the evening before surgery. On the day of sur-
gery, she received an additional oral pre-medication of
7.5 mg midazolam and was transferred smoothly to the
OR. Basic monitoring was applied and a peripheral ven-
ous line was installed. For induction of anaesthesia, mid-
azolam 5 mg, sufentanil 50 μg, propofol 50 mg, and
atracurium 50 mg i.v. were used. Endotracheal intub-
ation by direct laryngoscopy was difficult due to reduced
visibility on the vocal cords (Cormack & Lehane III), but
successful in the second attempt performing backwards
upwards rightwards pressure (BURP) and reclination of
the head. In parallel the second anaesthetist inserted an
arterial line and placed the transoesophageal echocardiog-
raphy probe (TEE) for haemodynamic and cardiac moni-
toring. In addition, a central venous catheter was inserted
into the left subclavian vein.
After induction of anaesthesia within preparation for
surgery, the patient developed hypotension followed byFigure 3 Original case TEE sequence in anaesthesia #4. A. acute onset
contractility: outer circle: diastole; inner circle: systole). B. after successful th
wall motion abnormalities (normal contractility: outer circle: diastole; innerST segment elevation. Simultaneously the apparently etio-
logic sudden onset of left-ventricular hypokinesia could be
detected by TEE (Figure 3A). This considerable haemo-
dynamic depression was instantly treated by application of
a fluid bolus and repetitive vasopressor support (Σ 100 μg
norepinephrine i.v.). Within few minutes haemodynam-
ics stabilized and the described echocardiographic
symptoms of left-ventricular function disorder diminished
(Figure 3B). Surgery, again by transnasal endoscopic ab-
scess evacuation, and the further course of anaesthesia
were uneventful except for another slight period of
discrete echocardiographic signs of the syndrome in-
traoperatively. Since symptoms were recognized early
and treated sufficiently, they diminished 1 min. after
appearance. In particular, mean arterial blood pressure
was treated to remain above 70 mmHg using continu-
ous low-dose application of norepinephrine with a syr-
inge pump. Although prepared for instant application,
neither inotropic support (in terms of milrinone and/or
epinephrine continuously) nor CPR was required in an-
aesthesia #4 even in the acute appearance of the cardio-
myopathy syndrome since haemodynamics never dropped
to intolerable levels. After surgery the patient was trans-
ferred to the ICU and was extubated 3 hours later. The
further course of medical treatment was completely un-
eventful and the patient was discharged to the normal
ward at day 3.
Anaesthesia #5 (Jul 2, 2013)
Due to recurrent rhinoliquorrhea out of the sellar floor
at the former surgery site and failure of conservative
treatment, another mucosal reconstructive surgery was
required. In this case, preparation and preoperative man-
agement were identical. Anaesthesia was performed by the
same team as in anaesthesia #4 accompanied by equal lo-
gistic and infrastructural preparations.of left ventricular dysfunction/considerable hypokinesia (reduced
erapeutic intervention: normal left ventricular function/no considerable
circle: systole).
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sufentanil 50 μg, propofol 50 mg, and atracurium 50 mg
were injected. Endotracheal intubation by direct laryngos-
copy was known to be difficult (Cormack & Lehane III)
but easily possible with the available video laryngoscope.
In parallel an arterial line for haemodynamic monitor-
ing was placed by the second anaesthetist without prob-
lems in the right femoral artery (not palpable in the radial
arteries) and a central venous catheter was installed. The
transoesophageal echocardiography probe for cardiac
monitoring was simultaneously positioned.
Shortly after induction of anaesthesia the patient devel-
oped hypotension, followed by bradycardia, ST-segment
elevation, and contractile dysfunction (left ventricular
hypokinesia as seen in the TEE similar to Figure 3A).
These symptoms resembled the situation described in an-
aesthesia #4 but haemodynamic depression and contract-
ile dysfunction were more pronounced and required
intermittent vasopressor and inotropic support as well as
a fluid bolus (∑ approx. 1 mg norepinephrine and 100 μg
epinephrine). Systolic blood pressure never dropped below
50 mmHg and symptoms diminished within few minutes
without the necessity for CPR since they were recognized
early (TEE and arterial line) and treated sufficiently. Fur-
ther treatment equalled anaesthesia #4 (continuous nor-
epinephrine for MAP strictly < 70 mmHg and prepared
milrinone) and the surgical period and the course of an-
aesthesia were completely uneventful. After surgery, the
patient was transferred to the ICU and was extubated
2 hours later. The further course remained uneventful and
the patient was discharged to a normal ward at day 3.
Case discussion
The annual incidence of Tako-Tsubo cardiomyopathy is
extremely low (approximately 0.00006% [1]) and the re-
currence of a Tako-Tsubo syndrome is infrequent. This
case series describes five repetitive anaesthesia procedures
in the same patient within sixteen months. Our reported
series shows are current Tako-Tsubo syndrome with simi-
lar clinical signs which were severe in every single case.
Anxiety about surgery or anaesthesia can be an incit-
ing factor [13]. Benzodiazepines may be a good choice
for sedation. However, more important as the drug itself,
it is required to obtain adequate pre-medication prior to
anaesthesia. A.K. Wong and colleagues presented a case
given only 1 mg of midazolam preoperatively which re-
sulted in an acute onset of Tako-Tsubo syndrome in their
patient [13]. Therefore, sufficient sedation and anxiolysis
in patients prior to scheduling for anaesthesia seems to be
beneficial. In our case, we have chosen to use lorazepam
and midazolam preoperatively in high doses to prevent
anxiety and stress.
Besides preoperative anxiolysis, deep anaesthesia dur-
ing intubation seems also to be beneficial. M. Brucoliand colleagues hypothesized that stress caused by super-
ficial anaesthesia, insufficient analgesia, and surgical pain
stimulus created a stressful event that can cause a poten-
tially life-threatening catecholamine release [1]. Also the
mechanism of TTC during anaesthesia or surgery could be
a neuro-cardiac interaction. For this reason, several mecha-
nisms can be entangled, part of the complex brain-heart
connection. Although our patient was in deep anaesthesia
(at least in cases #4 and #5), she developed the Tako-Tsubo
symptoms after endotracheal intubation but before sur-
gery has started. Additionally, our case was complicated
by a moderate difficult airway (C&L III) which was han-
dled by video laryngoscopy (#5) to prevent multiple intub-
ation attempts.
Some authors postulated that, if a Tako-Tsubo cardio-
myopathy is present, patients should be monitored by
invasive arterial measurements, placed in the awake pa-
tient. However, this is questionable since insertion of an
arterial cannula may also result in severe symptoms due
to stress and pain [7]. In the cases #2 and #3 an awake
arterial cannula was placed, but not in cases #4 and #5.
We had an extensive team discussion on this topic prior
to #4 and while working with two experienced specialists
for anaesthesiology, we chose placing the arterial line
after induction of anaesthesia to prevent unnecessary
stress. However, typical symptoms occurred after induc-
tion of anaesthesia.
The major pathophysiological phenomenon involved
in TTC is considered as disproportionate catecholamine
discharge in response to stress. This catecholamine ex-
cess is thought to stun the myocardium. In contrast,
milrinone is known as a non-catecholamine inotropic
drug improving myocardial contraction by inhibiting
type III phosphodiesterase. The initial choice of haemo-
dynamic support with norepinephrine is, therefore, per-
haps debatable as the Tako-Tsubo syndrome is related to
exaggerated sympathetic activation, and increased cat-
echolamine intake such as norepinephrine infusion could
worsen symptoms [17]. Milrinone, on the other hand, de-
creases the systemic vascular resistance and pulmonary
capillary wedge pressure. Furthermore, there is a lower in-
crease in the heart rate and myocardial oxygen consump-
tion with milrinone compared with catecholamines. But,
the induced peripheral vasodilatation by milrinone may
promote hypotension and may aggravate shock. Neverthe-
less, we have chosen a combination of norepinephrine and
epinephrine for inotropic and vasopressor support which
was clinically sufficient to treat symptoms.
In two of the presented five cases, CPR was required
(5 min vs. 30 min), resulting in a very unstable haemo-
dynamic situation. Therefore, it might be beneficial to have
an intra-aortic balloon pump (IABP) available for haemo-
dynamic support. In our case #3, haemodynamic situation
after 30 min of CPR was very unstable. Installation of
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(ECMO) was discussed interdisciplinary but surrendered.
It is remarkable that severe TTC symptoms in this fe-
male patient were found during every anaesthesia proced-
ure. Additionally, although she was resuscitated two times
(in case #3 with therapeutic hypothermia for 2 days), there
was no neurological or cognitive deficit detectable.
Recommendations for anaesthesia in patients with se-
vere TTC:
 Anaesthesia and surgery should be performed in
large centres (sufficient personnel).
 Proper preoperative diagnostics is required. Check,
if coronary catheterization is necessary.
 ICU must be available.
 Discuss crisis management and make
interdisciplinary agreements.
 The anaesthesiologist should be experienced, should
know TTC in detail and know how to react in case
of a problem.
 Anaesthesia should be performed by two
experienced anaesthetists
 Adequate medical premedication at the evening
before surgery and the morning of surgery.
 Patient should be transported to OR without stress,
preferably first position (under deep sedation and
anxiolysis)
 Consider arterial line in the awake patient, but when
anaesthetized seems more beneficial
 Perform deep anaesthesia for endotracheal
intubation
 TEE should be used for detection of Tako-Tsubo
symptoms since a dynamic left ventricular
outflow tract obstruction (LVOTO) is reported in
TTC-associated cardiogenic shock. Maintain good
left ventricular preload to avoid LVOTO.
 Possibility to place urgently an intra-aortic balloon
pump (IABP)
 ß-blockers seem to have beneficial effects
Literature review
Recent literature published
The term “Tako-Tsubo” was initially used, because the
morphological feature of a left end-systolic ventriculo-
gram shows a balloon-shaped, short-necked, round flask
resembling a Tako-Tsubo, a device used to trap octo-
puses in Japan (Figure 1) [19].
A literature search in Medline™/PubMed™ revealed only
19 hits for “TakoTsubo” and “anaesthesia” and 66 hits for
“Takotsubo” and “anaesthesia” starting in the year 2002.
When using “broken heart syndrome” and “anaesthesia”
or “anaesthesiology” a total of 63 vs. 31 hits were found.
There were no randomized controlled trials (RCT) found
on this topic.Prevalence, pathogenesis, and prognosis
Today, the exact prevalence of the Tako-Tsubo syndrome
is not known [20]. It is estimated at 2–8 per year and per
1 million inhabitants. Altogether more than 1,000 cases
have been reported [21] but only few during anaesthesia.
The syndrome was reported both in male [9,22] and fe-
male patients, but most reported cases of this syndrome
(more than 90-95%) affect elderly women [7] being older
than 60 years [22] or being postmenopausal [1,5,8,20].
The average age at diagnosis is 68 years [21]; however, a
few cases have been described in paediatric patients [21].
Although the pathogenesis of Tako-Tsubo cardiomyop-
athy in not completely understood, catecholamine-mediated
myocardial stunning due to enhanced sympathetic activity
is the most widely accepted underlying mechanism [23].
From a clinical point of view, this syndrome can be similar
to the acute coronary syndrome in awake patients which
is the major differential diagnosis. Because the precise
aetiology of the Tako-Tsubo cardiomyopathy remains un-
clear, there is no consensus for treatment during the acute
phase [7].
Transient life-threatening complications were occasion-
ally reported, including pulmonary oedema, cardiogenic
shock, dynamic intraventricular obstruction, ventricular
arrhythmias or ventricular fibrillation, rupture of the left
ventricular wall, and death [19].
Although most patients recover without complications
after an acute episode of Tako-Tsubo cardiomyopathy,
15%-45% of patients with an acute onset of symptoms de-
velop cardiogenic shock and require inotropic and vaso-
pressor support [4,6,8]. Other severe complications as
ventricular fibrillation or cardiac arrest as well as death re-
sult in up to 21% of cases, respectively [4,13]. However, the
patient’s initial prognosis is generally good after appropri-
ate treatment of acute phase complications [19]. Neverthe-
less, in-hospital mortality is estimated with approximately
1.1% to 2.0% (range 0%-8% [13]) [6,21].
Following an acute episode, left-ventricular dysfunction
usually resolves within several days or weeks [7] and
an almost complete recovery is seen in 96% of the pa-
tients [24]. The prognosis of patients with TTC is
usually good [7,10,12]. The risk of recurrence of this
syndrome is low, and estimated at 0% to 11.4% up to
4 to 5 years after the initial episode [6,12,13,24], but it
is unpredictable.
How to best prevent perioperative Tako-Tsubo cardiomy-
opathy and whether there is a best anaesthetic technique to
use in patients with necessity for surgery who have experi-
enced the syndrome previously is still unclear [4].
Anaesthesia considerations
In several series, about 13% (6% to 16%) of cases oc-
curred perioperatively [4,24]. Anxiety about surgery or
anaesthesia can be an inciting factor [13]. No established
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stratification nor for treatment of patients with Tako-
Tsubo cardiomyopathy [25]. Therefore, the ideal anaes-
thetic management of patients with TTC is unknown
[7]. In combination with the rarity of the syndrome and
thus the likeliness to become confronted with a first on-
set of the syndrome unprepared clearly makes it a chal-
lenge even for experienced anaesthesiologists [12]. This
is more so, since the pathogenic correlates are less easily
identified during anaesthesia [16].
Perioperative management strategy consists of both
prophylactic and therapeutic components. One principle
goal is to avoid psychological and physical stress that
could trigger an acute episode of the cardiomyopathy
[7,10,12]. The resulting centre column of prophylaxis is
a sufficient anxiolysis which requires both psychological
and pharmacologic approaches [7].
Additionally, an extensive anaesthesia anamnesis and
information of the patient is essential. Besides ß-blocker
therapy, there is no evidence to support any specific man-
agement strategy or drug therapy for the prevention of
onset or recurrence. However, providing a rather deeper
level of anxiolysis and sedation prior to transportation to
the operating room might be beneficial [13].
Although it was suggested that regional anaesthesia (RA)
may be a good alternative to general anaesthesia (GA) [7],
this question is not finally answered and there is no con-
sensus yet [7].
There were several drugs used for anaesthesia both in
our case and other case reports (Table 1) and a definite
connection between specific drugs and the emergence of
acute TTC symptoms is not known. Laryngoscopy and in-
tubation may cause the specific symptoms [17] and should
therefore be brief to minimize sympathetic stimulation.
ECG changes including dynamic ST-elevation should be
carefully monitored [7].
Smooth emergence and extubation are also essential
to avoid increases in catecholamines that may trigger
these cardiac symptoms [7,14]. Postoperatively, patients
should stay in the intensive care unit (ICU) for vigilantTable 1 Previously used anaesthesia drugs in patients
with Tako-Tsubo cardiomyopathy
Drug group Substance Citation
Sedation Midazolam [7]
Analgetics Fentanyl [3,7,16]
N2O [7]
Sufentanil [17]
Hypnotics Propofol [3,7,16,17]
Sevoflurane [3,7,16]
Muscle relaxants Rocuronium [3,7]
Cisatracurium [16]monitoring and adequate pain control because symptoms
frequently occur in the postoperative period [12,14].
Acute episode
Although atropine was administered to treat resulting
symptoms in some case reports [9] and in one of our
cases, it is usually not recommended during symptom-
atic Tako-Tsubo cardiomyopathy [23]. The withdrawal of
parasympathetic drive in such cases should exacerbate
sympathetic activity, leading to the genesis or worsening
of disease activity [23]. This effect was observed in some
cases [9,23].
Maintenance of a sufficient mean arterial pressure to se-
cure adequate coronary perfusion is essential and may de-
mand the application of vasopressors. Inotropic support
may be necessary but has to be monitored carefully since
stimulation of β1-receptors by endogenous catecholamines
is one of the discussed pathogenetic factors in the develop-
ment of TTC. Also a dynamic obstruction in the left ven-
tricular outflow tract (LVOT) similar to systolic anterior
motion (SAM) may occur or be aggravated by inotropic
agents when administered without echocardiographic
monitoring.
A dynamic left ventricular outflow tract obstruction
(LVOTO) is reported in TTC-associated cardiogenic shock
[26]. Indeed, low left ventricular diastolic filling pressure,
hyperdynamic motion of basilar walls, eventually pre-
existing basal septal hypertrophy, and inappropriate cat-
echolamine treatment could all cause dynamic LVOTO.
For this reason, maintaining good left ventricular preload
and reducing dynamic LVOTO could be the main thera-
peutic target in TTC cardiogenic shock. Complete haemo-
dynamic monitoring integrated with TEE is essential to
establish proper management and avoid unnecessary or
harmful pharmacological intervention.
Therefore, both transthoracic and transoesophageal
echocardiography mark an important monitoring com-
ponent as they can identify regional wall motion abnor-
malities of the left ventricle [3] and therefore guide
specific therapeutic interventions and directly show their
effects. They should thus be a standard during anaesthe-
sia in these patients.
Conclusion
Tako-Tsubo syndrome is an adverse event that may
occur at induction of general anaesthesia, whose rela-
tionships with anaesthesia and surgical stress should be
studied because of its specific course, which is different
from typical myocardial ischemia [16].
This case series is remarkable since the severe symp-
toms occurred during every anaesthesia procedure. The
female patient was resuscitated two times including
therapeutic hypothermia, but fortunately no neurological
or cognitive deficit was detectable.
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tablish the most effective treatment options in patients
with Tako-Tsubo cardiomyopathy. Additionally, it would
be very helpful to establish clinical registries on this syn-
drome to gain further insight into the pathogenesis and
treatment in patients during anaesthesia.
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